GeneTex
  • Country / Location Selection

United States (US)

Osteopontin/SPP1 blocking peptide

Cat No. GTX89519-PEP

Species

Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX89519.

PROPERTIES

Form

Lyophilized powder

Buffer

Lyophilized from 5% (v/v) acetonitrile/H₂O. Reconstitute pellet in 200μl distilled water to obtain a 0.5mg/ml peptide solution.

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-DPKSKEEDKHLK

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

Secreted Phosphoprotein 1 , Bnsp , Bspi , Eta-1 , Opn , Spp1

Background

The protein encoded by this gene is involved in the attachment of osteoclasts to the mineralized bone matrix. The encoded protein is secreted and binds hydroxyapatite with high affinity. The osteoclast vitronectin receptor is found in the cell membrane and may be involved in the binding to this protein. This protein is also a cytokine that upregulates expression of interferon-gamma and interleukin-12. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

Research Area

REFERENCE

There are currently no references for Osteopontin/SPP1 blocking peptide (GTX89519-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for Osteopontin/SPP1 blocking peptide (GTX89519-PEP). Be the first to share your experience with this product.